Of note, MMP-11 expression was detected in these CAFs across all three molecular subtypes of breast cancer, with a notable prevalence in HER2-positive tumors and, to a lesser extent, in estrogen receptor-positive cancers. Here, MMP11 is linked to breast carcinoma.